Loading clinical trials...
Loading clinical trials...
Researchers are looking for new ways to treat neovascular age-related macular degeneration (NVAMD). Available standard (usual) treatments for NVAMD, such as aflibercept, may not work for every person...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
EyeBiotech Ltd.
NCT05803785 · Age-Related Macular Degeneration
NCT07392255 · Geographic Atrophy Secondary to Age-related Macular Degeneration
NCT07550777 · Diabete Mellitus, Retina Vein Occlusion, and more
NCT05407636 · AMD, nAMD, and more
NCT07308639 · Neovascular Age-related Macular Degeneration (nAMD); Diabetic Macular Edema (DME); Retinal Vein Occlusion (RVO)
Retinal Consultants Medical Group (Site 024)
Modesto, California
Retina Consultants of Southern California (Site 043)
Redlands, California
Retinal Consultants Medical Group (Site 020)
Sacramento, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions